Skip to main content
Livermore
Livermore
ZHEN

Context Therapeutics Inc.

CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001842952

No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Context Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
42
−9 vs. Q4 2024
Shares held
71.4M
+6.03M (+9.2%) vs. Q4 2024
Total value
$43.7M
−$24.9M (−36.3%) vs. Q4 2024
New holders
3
6 more added
Sold out
12
14 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 42 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 20 institutionsQ3 2022: 24 institutionsQ4 2022: 24 institutionsQ1 2023: 22 institutionsQ2 2023: 22 institutionsQ3 2023: 23 institutionsQ4 2023: 24 institutionsQ1 2024: 25 institutionsQ2 2024: 34 institutionsQ3 2024: 42 institutionsQ4 2024: 52 institutionsQ1 2025: 42 institutionsQ2 2025: 39 institutionsQ3 2025: 37 institutionsQ4 2025: 43 institutionsQ1 2026: 60 institutionsQ2 2026: 79 institutions
Value heldQ1 2025: $43.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $9.44MQ1 2022: $6.30MQ2 2022: $6.32MQ3 2022: $4.59MQ4 2022: $2.55MQ1 2023: $722.6KQ2 2023: $3.58MQ3 2023: $3.89MQ4 2023: $4.02MQ1 2024: $5.43MQ2 2024: $114.3MQ3 2024: $111.2MQ4 2024: $76.4MQ1 2025: $43.7MQ2 2025: $45.0MQ3 2025: $66.8MQ4 2025: $96.0MQ1 2026: $194.6MQ2 2026: $34.8M
Institutions holding CNTX and their total value by quarter
QuarterHoldersValue
Q2 202679$34.8M
Q1 202660$194.6M
Q4 202543$96.0M
Q3 202537$66.8M
Q2 202539$45.0M
Q1 202542$43.7M
Q4 202452$76.4M
Q3 202442$111.2M
Q2 202434$114.3M
Q1 202425$5.43M
Q4 202324$4.02M
Q3 202323$3.89M
Q2 202322$3.58M
Q1 202322$722.6K
Q4 202224$2.55M
Q3 202224$4.59M
Q2 202220$6.32M
Q1 202216$6.30M
Q4 202119$9.44M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q4 2024.

Institutions holding CNTX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
JPMorgan Chase & Co80$490.00%−86−51.8%Reduced
Morgan Stanley100$610.00%−127−55.9%Reduced
SBI Securities Co., Ltd.113$690.00%00.0%Unchanged
UBS Group AG432$2640.00%−698,697−99.9%Reduced
Bank of America Corp444$2720.00%−5,813−92.9%Reduced
Advisor Group Holdings, Inc.10,000$6.10K0.00%−500−4.8%Reduced
Cerity Partners LLC10,000$6.12K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)13,304$8.14K0.00%+12,370+1,324.4%Added
Congress Wealth Management LLC15,000$9.18K0.00%+15,000New
XTX Topco Ltd15,673$9.59K0.00%+15,673New
Caxton Corp18,403$11.3K0.22%00.0%Unchanged
Landscape Capital Management, L.L.C.41,216$25.2K0.00%−48,784−54.2%Reduced
Millennium Management LLC48,671$29.8K0.00%−130,047−72.8%Reduced
Clear Harbor Asset Management, LLC57,804$35.4K0.00%00.0%Unchanged
UBS Oconnor LLC67,631$41.4K0.00%−241,127−78.1%Reduced
Velan Capital Investment Management LP90,000$55.1K0.06%00.0%Unchanged
Northern Trust Corp113,565$69.5K0.00%00.0%Unchanged
HighTower Advisors, LLC125,852$77.0K0.00%00.0%Unchanged
State Street Corp152,607$93.4K0.00%00.0%Unchanged
Walleye Capital LLC168,960$103.4K0.00%+2,654+1.6%Added
Qube Research & Technologies Ltd174,309$106.7K0.00%−148,529−46.0%Reduced
Shay Capital LLC189,853$116.2K0.03%+139,853+279.7%Added
ADAR1 Capital Management, LLC351,094$214.9K0.04%00.0%Unchanged
Renaissance Technologies LLC425,500$260.4K0.00%+87,065+25.7%Added
Geode Capital Management, LLC639,219$391.4K0.00%+10,490+1.7%Added
Affinity Asset Advisors, LLC660,589$404.3K0.06%−354,751−34.9%Reduced
BlackRock, Inc.848,970$519.6K0.00%−63,435−7.0%Reduced
Allostery Investments LP950,166$581.5K0.84%00.0%Unchanged
Ally Bridge Group (NY) LLC1,157,448$708.4K0.64%−419,314−26.6%Reduced
Sio Capital Management, LLC1,328,352$813.0K0.25%00.0%Unchanged
Woodline Partners LP1,361,188$833.0K0.01%−1620.0%Reduced
Alyeska Investment Group, L.P.1,663,355$1.02M0.00%00.0%Unchanged
Nantahala Capital Management, LLC1,935,484$1.20M0.10%00.0%Unchanged
Blackstone Group Inc.2,440,330$1.49M0.01%00.0%Unchanged
Vanguard Group Inc3,253,467$1.99M0.00%−1,996−0.1%Reduced
Franklin Resources Inc4,003,380$2.45M0.00%00.0%Unchanged
Great Point Partners LLC4,683,711$2.87M1.56%00.0%Unchanged
Blue Owl Capital Holdings LP7,367,906$4.51M1.45%+1,009,978+15.9%Added
Deep Track Capital, LP7,419,355$4.54M0.15%00.0%Unchanged
Nextech Invest, Ltd.7,419,355$4.54M1.06%+7,419,355New
Avidity Partners Management LP7,477,200$4.58M0.94%00.0%Unchanged
MPM Oncology Impact Management LP14,705,882$9.00M1.55%00.0%Unchanged
Marshall Wace, LLP0$00.00%−203,286−100.0%Sold out
Mill Creek Capital Advisors, LLC0$00.00%−104,631−100.0%Sold out
Citigroup Inc0$00.00%−54,454−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−52,792−100.0%Sold out
Citadel Advisors LLC0$00.00%−29,900−100.0%Sold out
Jane Street Group, LLC0$00.00%−27,395−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−27,122−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−22,710−100.0%Sold out
Acadian Asset Management LLC0$00.00%−16,668−100.0%Sold out
Virtu Financial LLC0$00.00%−11,638−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−10,185−100.0%Sold out
United Capital Management of KS, Inc.0$00.00%−10,000−100.0%Sold out
Nextech Invest AG––––Not filed